A question on #ProstateCancer #Drugs tabled by Clive Jones on 17-06-2025 has been answered by Karin Smyth.

Heading: Prostate Cancer: Drugs
Question ID: 1813606
UIN: 60697
House: Commons
Date tabled: 2025-06-17
Asking Member ID: 5207
Asking Member display name: Clive Jones
Asking Member handle:
Asking Member Twitter reference: Clive Jones
Member interest: false
Question text: To ask the Secretary of State for Health and Social Care, what assessment he has made on the potential impact of abolishing NHS England on the availability of (a) abiraterone and (b) other similar drugs.
Is named day: false
Date of holding answer:
Date answered: 2025-06-26
Date answer corrected:
Is holding answer: false
Is correcting answer: false
Answering Member ID: 4444
Answering Member display name: Karin Smyth
Answering Member handle: karinsmyth
Answering Member Twitter reference: @karinsmyth
Correcting Member ID:
Correcting Member display name:
Correcting Member handle:
Correcting Member Twitter reference:
Answer text: Whilst this transformation takes place, we will ensure that we continue to evaluate impacts of all kinds and will work collaboratively to ensure continuity of care and that there are no risks to patient safety. Throughout the organisational change, NHS En...
Original answer text:
Comparable answer text:
Answering body ID: 17
Answering body name: Department of Health and Social Care
Tweeted: true